KALV stock - KalVista Pharmaceuticals Inc

Exchange: NASDAQ

Fri 16'th Nov 2018

PERIOD 2018-08-17 - 2018-11-16
CHANGE 4.14%
PRICE $18.85




Request Prediction

KalVista Pharmaceuticals Inc Stock Analysis

Technical stock analysis for Fri 16'th Nov 2018

Hold candidate since 2018-11-15 Gain 4.14%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.87
ROA -35.99

KalVista Pharmaceuticals Inc gained 4.14% in the last trading day, rising from $18.10 to $18.85 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 7 of the last 10 days and is down by -4.75% for this period. Volume fell in the last day by -39 039 shares, and in total, 70 823 shares bought and sold for approximately $1.34 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


KalVista Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.15% during the next 3 months and, with 90% probability hold a price between $19.34 and $27.56 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Wednesday November 14, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. KalVista Pharmaceuticals Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $19.15. On a fall, the stock will find some support from the short-term average at $18.19. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 52 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

KalVista Pharmaceuticals Inc finds support from accumulated volume at $18.18.

Support: $18.18 Price: $18.85 Resistance: $19.77


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $1.72 between high and low, or 9.81%. For the last week the stock has had a daily average volatility of 9.59%.

Our recommended stoploss: $18.09 (-4.03%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High


KalVista Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.

KALV $18.85 $0.75(4.14%)
KALV is up $0.75 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for KALV based on the 1-3 month system that more than doubles the S&P 500.

Click here – the KALV analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with